Drug Topics

AUGUST 11, 2023

HHS awards money to fight the nursing shortage, the FDA approves Johnson & Johnson's talquetamab-tgvs (TALVEY), and the CDC says suicides reached an all-time high in 2022.

FDA 468

FDA 468

PharmaVoice

AUGUST 11, 2023

The long-time pharma exec on her most recent wins, her favorite rule to break and the words she lives by.

130

130

Drug Topics

AUGUST 11, 2023

A substantial collection of evidence indicates that the fallopian tube serves as the primary site of origin for a large portion of high-grade serous ovarian cancers.

247

247

Pharmacy Times

AUGUST 11, 2023

Jennifer Chesak, author of The Psilocybin Handbook for Women, discusses how estrogen can affect binding at the serotonin receptor sites, causing psilocybin to impact women’s bodies differently.

123

123

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

AUGUST 11, 2023

According to the National Community Pharmacists Association, 97% of independent pharmacy owners reported shortages of Adderall in early 2023.

Independent Pharmacies 247

Independent Pharmacies 247

Pharmacy Times

AUGUST 11, 2023

Gretchen Garofoli, PharmD, an associate professor at the West Virginia School of Pharmacy, discusses the current recommendations for COVID-19, respiratory syncytial virus (RSV), and influenza vaccines and vaccine hesitancy.

Vaccines 123

Vaccines 123

Pharmacy Times

AUGUST 11, 2023

Pharmacy technicians are stepping up to assume expanded responsibilities that contribute to pharmacy management and patient safety.

123

123

STAT

AUGUST 11, 2023

Nearly every hospital pharmacy across the U.S. is experiencing shortages of prescription drugs. And the problem has become so bad – especially for chemotherapies — that one-third of hospital pharmacists reported their institutions are rationing, delaying, or canceling treatments or procedures, according to a new survey. Specifically, 99% of hospitals pharmacists reported shortages, which is causing 85% to ration treatments and 84% to rely on different dosages.

Hospitals 98

Hospitals Compounding Pharmacies Chemotherapy Compounding 98

Pharmacy Times

AUGUST 11, 2023

Unexpectedly, the highest increases in delirium compared to projections were in the 66 to 74 years of age group, which could have important personal and societal repercussions, such as earlier development of dementia.

Hospitals 123

Hospitals 123

Fierce Healthcare

AUGUST 11, 2023

Microsoft rolled out a new electronic health records cloud database solution, leveraging Azure Large Instances, that enables health systems to scale capacity for high-volume workloads. | Microsoft rolled out a new electronic health records cloud database solution, leveraging Azure Large Instances, that enables health systems to scale capacity for high-volume workloads.

98

98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

AUGUST 11, 2023

New standards from the National Council for Prescription Drug Programs could drive changes that improve patient safety by optimizing drug therapy to reduce the risk of harm and improve health and well-being before a medication is dispensed.

123

123

PharmExec

AUGUST 11, 2023

How pharma medical affairs and commercial teams are synchronizing their capabilities to boost omnichannel marketing strategies and better understand customer engagement needs.

98

98

Pharmacy Times

AUGUST 11, 2023

Despite the low uptake of healthy lifestyle behaviors to achieve 5% weight loss or greater, the probability of weight loss increased among individuals with higher initial BMI.

123

123

Drug Store News

AUGUST 11, 2023

Cloud Pink is inspired by the singer’s optimism and confidence, and its campaign will showcase her as both an artist and woman, the company said.

98

98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

AUGUST 11, 2023

In the COLUMBUS study, the FDA requested that the investigators evaluate the contribution of binimetinib while maintaining the same dosage of encorafenib at 300 mg to confirm the benefits of the combination.

Dosage 122

Dosage FDA 122

The Checkup by Singlecare

AUGUST 11, 2023

Pain management is essential to the treatment plan when someone is suffering. However, figuring out the right course of action for a particular condition can be difficult. There are many ways to worsen and prolong pain if not managed properly. People with diverticulitis often experience abdominal pain during or after eating a meal. Eating is a part of everyday life, so coping with a condition that is worsened by eating can be challenging.

98

98

Pharmacy Times

AUGUST 11, 2023

The study implemented a novel workflow for ambulatory care pharmacists to execute pharmacist-administered depression screenings.

122

122

STAT

AUGUST 11, 2023

WASHINGTON — A White House task force created to work on drug shortage reforms has yet to contact the lawmakers who are writing legislation to stem shortages — and it’s not clear when the task force will recommend policies. The White House formed a task force at the beginning of 2023 to deal with the issue of persistent drug shortages.

Chemotherapy 98

Chemotherapy Hospitals 98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

AUGUST 11, 2023

Precision therapies, although effective in earlier stages, may not work later.

122

122

Fierce Healthcare

AUGUST 11, 2023

Access to care for Medicaid fee-for-service beneficiaries with substance use disorder has improved from 2014 until 2021, but much more can be done to improve it further, researchers say. | There have been substantial improvements in coverage for substance use disorder and opioid use disorder since 2014, according to a study in JAMA Network. Nonetheless, there’s room for yet more improvement.

98

98

Pharmacy Times

AUGUST 11, 2023

Although SB5 is an effective treatment for plaque psoriasis, it is recommended that patients consider the potential risks and adverse effects.

122

122

PharmExec

AUGUST 11, 2023

From public defender to spearheading the adoption of innovative drugs, Wendy Short Bartie, senior VP and general manager for the hematology and cell therapy division at Bristol Myers Squibb, has remained a steadfast patient advocate—working to fulfill unmet medical needs and bring treatments to as many people as possible.

98

98

Pharmacy Times

AUGUST 11, 2023

Advancements in the development of amyloid-targeting monoclonal antibodies show promise for treating Alzheimer disease, but there have been concerns around cost, adverse reactions, and inequity of care for marginalized patients.

Adverse Reactions 122

Adverse Reactions 122

The Checkup by Singlecare

AUGUST 11, 2023

Propranolol is an old drug that just won’t go away, for good reason. It touts a 50-year history of utility, originally as a treatment for heart disease and later as a preventive treatment for migraine, a use that has landed it on the World Health Organization’s list of essential medications. A role for propranolol that you may find more interesting is in the treatment of anxiety.

FDA 98

FDA Dosage Labelling Insurance 98

Drug Store News

AUGUST 11, 2023

Shoppers across the Midwest can access same-day delivery on their grocery items and enter the exclusive sweepstakes.

98

98

Pharmaceutical Technology

AUGUST 11, 2023

Following the business expansion in 2022, Clinigen announced the divestment of four of its cancer therapies.

98

98

Drug Store News

AUGUST 11, 2023

Alwood Pharmacy was honored as the recipient of Good Neighbor Pharmacy’s annual Pharmacy of the Year award.

Community Pharmacies 98

Community Pharmacies 98

PharmExec

AUGUST 11, 2023

Continued approval to be based on verification and description of clinical benefit in confirmatory trials.

FDA 98

FDA 98

Drug Store News

AUGUST 11, 2023

Grocery Doppio's survey of the grocery industry reveals opportunities for grocers to leverage technology and shopper data, and finds that third-party apps are in trouble.

98

98

Fierce Healthcare

AUGUST 11, 2023

The Department of Justice (DOJ) is requesting more information from Amedisys regarding its proposed $3.3 billion deal to be acquired by UnitedHealth Group, which pushes back the timing of the deal. | The Department of Justice is requesting more information from Amedisys regarding its proposition $3.3 billion acquisition by UnitedHealth Group, which pushes back the timing of the deal.

98

98

Pharmaceutical Commerce

AUGUST 11, 2023

MIT’s Barbara Wixom, PhD, outlines the importance of data-powered research in producing financial success.

98

98

European Pharmaceutical Review

AUGUST 11, 2023

The European Commission has revoked the conditional marketing authorisation (MA) for Novartis’ sickle cell medicine crizanlizumab in the European Union (EU) and EEA. The decision follows a May recommendation from the European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP). Crizanlizumab is a once-a-month, humanised monoclonal antibody infusion, indicated for the prevention of recurrent vaso‑occlusive crises (pain crises) in sickle cell disease patients aged 16 yea

FDA 98

FDA 98

pharmaphorum

AUGUST 11, 2023

Strong solutions for increasing dermatology research diversity: Trust me, I’ve got skin in the game Mike.

98

98